Fall Investor Preview Along With A Belated August Recap

I’ve held off on my August recap much like a war veteran will refrain from telling tales from the trenches. Not that my experiences...

If I Had A Nickel For Every Buying Opportunity…

The path to being a good investor is to be able to see what the future holds and place your bets accordingly. If you...

In Defense of CATS

Shares of Catasys (CATS) are down over 15% as I write this article. Trading at close to $15 a share, the stock has retreated...

Catasys Reports 2019 Second Quarter Financial Results

Tailwinds' Take: solid growth, although shy of the Street forecasts. Guidance, as always, very strong. Conference call will determine near-term direction. Longer-term, things look...

Catasys Expands Partnership with Leading National Health Plan

Tailwinds' Take: this expansion should easily bring their eligible lives to well over 100,000. It also demonstrates that the program is working as Aetna...

Recapping The Week That Was…And Looking Towards Next

This was a very hectic week in the market, with major swings in the indexes and in our universe of smaller companies. Earnings season...

CATS: This Is Bigger Than You Think

Sometimes big news falls on deaf ears. Which, by the way, is one of the reasons I like the micro-cap space. With only a...

Catasys Launches Breakthrough AI Capability to Address Chronic Disease

Tailwinds' Take: this is potentially the most significant announcement in CATS' history. They are using their AI to expand their product line significantly. I...

Catasys Appoints Industry Veteran Rob Rebakto Board of Directors

Los Angeles, CA - July 18, 2019 - Catasys, Inc. (NASDAQ: CATS) ("Catasys" or the "Company"), a leading AI and technology-enabled healthcare company, today...

Catasys Appoints Healthcare Executive Daniel Prewitt as Senior Vice President of Sales

Los Angeles, CA – June 26, 2019 – Catasys, Inc. (NASDAQ: CATS) ("Catasys" or the "Company"), a leading AI and technology-enabled healthcare company, today...

A Shallow Dive From The Deep South

In what is shaping up as a never-ending quest to provide newsletter coverage from anyplace not named "home", this week's letter comes from Raleigh,...

Catasys Adds Canary Health to OnTrak Platform

Los Angeles, CA – June 6, 2019 – Catasys, Inc. (NASDAQ: CATS) ("Catasys" or the "Company"), a leading AI and technology-enabled healthcare company, today...

Markets Trade Down In May…June Preview

I'm not sure why, but it seems that every time I feel the Tailwinds' Portfolio is poised for big gains, the market enters a...

B Riley, Day One

Today was the first day of the B Riley Conference in Los Angeles at the Beverly Hilton, a hotel that has a 60's feel...

Catasys Reports 2019 First Quarter Financial Results

LOS ANGELES Q1 2019 Record Revenue of $6.8 Million, Up 256% Year over Year and Up 21% from Q4 2018 Outreach Pool of Eligible...

Catasys Announces Proprietary Interventions for Treatment of Loneliness Epidemic

Tailwinds' Take: launching into treatment of another disorder demonstrates the potential of the OnTrak platform for horizontal expansion across any behavioral health issue. Catasys...

Catasys Announces Partnership with Circulation and Lyft

Los Angeles, CA - May 8, 2019 - Catasys, Inc. (NASDAQ: CATS) ("Catasys" or the "Company"), a leading AI and technology-enabled healthcare company, today...

Catasys Expands OnTrak-C Solution with Leading National Health Plan

Tailwinds' Take: Centene is expanding coverage, demonstrating the positive impact of OnTrak. Depression and anxiety are much bigger indications than addiction in terms of...

Catasys Expands OnTrak-Ci Solution with Leading National Health Plan’s Eligible Medicare Advantage Members in...

Tailwinds' Take: Cigna continuing expansion is further proof of the effectiveness of OnTrak. CATS is poised to blow away forecasts over the next 12-24...

CATS: The Suicide Squeeze Is On

I'm not a big fan of getting involved in stocks with big short positions. Short sellers, in general, are very smart investors. They do...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.